The U.S. Food and Drug Administration (FDA) has accepted a new drug application from Jazz Pharmaceuticals for a capsule ...
Terpenes and minor cannabinoids found in marijuana can influence pain signaling through biological mechanisms that extend ...
A preclinical study reports that cannabidiol selectively impaired viability, migration, invasion, and clonogenic survival of ...
Management attributes the raised 2026 revenue guidance to outstanding field execution and a slower-than-anticipated impact ...
Among people with premenstrual symptoms who used cannabis, the amount of dried flower they consumed tended to climb in the ...
Canna River's CBD + CBN Sleep Gummies contain 50mg of each cannabinoid per gummy. The review examines their formulations, THC content, evidence, pricing, and safety considerations.
Medical cannabis may offer little meaningful benefit for people with insomnia, according to a new review published in the ...
Founded by husband and wife team Levi Levenfiche and Marisa Poster, alongside Levi's younger brother Teddie, the green tea ...
A discussion of workplace drug and alcohol use, abuse, and testing, focusing on private employers’ compliance with state and ...
Zacks Investment Research on MSN
JAZZ Q3 earnings & sales beat estimates, raises '26 sales view
Jazz Pharmaceuticals JAZZ reported a third-quarter 2026 adjusted loss of $3.88 per share, narrower than the Zacks Consensus Estimate of a loss of $4.09. In the year-ago period, the company posted ...
Leonardo spends up to R$ 5,000 a month on cannabidiol and fears losing access to treatment; STJ ruling limits health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results